RECRUITING

DISCO: A Patient Intervention to Reduce the Financial Burden of Cancer

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The DISCO App is designed to improve, during the interaction, patient active participation and patient-initiated oncologist treatment cost discussions, and, in the short term, patient's treatment cost knowledge, self-efficacy for managing both cost and physician interactions, referrals, perceived financial toxicity (i.e., distress and material hardship); in turn, these will affect longer-term outcomes of financial toxicity and adherence.

Official Title

DISCO: A Patient Intervention to Reduce the Financial Burden of Cancer

Quick Facts

Study Start:2021-02-10
Study Completion:2025-08-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04766190

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Oncologists are eligible if they treat patients with breast, prostate, lung, or colorectal cancers at Karmanos Cancer Institute. Data from oncologists will include their self-report data and video-recorded treatment discussions with participating patients.
  2. * Patients: Must be able to read and write in English; have an email account; and are newly diagnosed with breast, prostate, lung or colorectal cancer (stage I-IV) for which systemic therapy is a likely recommended treatment. Data from patients will include their self-report data, video-recorded treatment discussions with participating oncologists, and medical record data
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

Lauren Hamel, PhD
CONTACT
313-576-9672
hamell@karmanos.org

Principal Investigator

Lauren Hamel, PhD
PRINCIPAL_INVESTIGATOR
Barbara Ann Karmanos Cancer Insitute

Study Locations (Sites)

Barbara Ann Karmanos Cancer Institute
Detroit, Michigan, 48201
United States

Collaborators and Investigators

Sponsor: Lauren Hamel

  • Lauren Hamel, PhD, PRINCIPAL_INVESTIGATOR, Barbara Ann Karmanos Cancer Insitute

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2021-02-10
Study Completion Date2025-08-31

Study Record Updates

Study Start Date2021-02-10
Study Completion Date2025-08-31

Terms related to this study

Keywords Provided by Researchers

  • Financial Toxicity
  • Cancer
  • Treatment cost
  • Patient-provider communication

Additional Relevant MeSH Terms

  • Financial Toxicity
  • Cancer
  • Question Prompt List
  • Breast Cancer
  • Prostate Cancer